Christopher J Pepper (Chris Pepper, Chris J Pepper, Christopher Pepper)

Loop profile ORCID

Publication Activity (10 Years)

Years Active: 2016-2024
Publications (10 Years): 24

Top Venues

Brighton and Sussex Medical School, University of Sussex

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Brighton and Sussex Medical School, University of Sussex Apr 01 2017

United Kingdom

Professor of Cancer Research :: Clinical and Experimental Medicine

Cardiff University, academic/Medicine Nov 01 2014 - Mar 31 2017

United Kingdom

Professor and Dean of Research :: Division of Cancer & Genetics

Publications

Hussein N Al-Ali, Scott J Crichton, Charlene Fabian, Christopher J Pepper, David R Butcher, Fiona C Dempsey, Christopher N Parris
A therapeutic antibody targeting annexin-A1 inhibits cancer cell growth in vitro and in vivo. Oncogene 43 (8) (2024)
Hussein N Al-Ali, Scott J Crichton, Charlene Fabian, Christopher J Pepper, David R Butcher, Fiona C Dempsey, Christopher N Parris
A therapeutic antibody targeting annexin-A1 inhibits cancer cell growth in vitro and in vivo. Oncogene (2024)
Richard Norris, John Jones, Erika Mancini, Timothy Chevassut, Fabio A Simoes, Christopher J Pepper, Andrea G S Buggins, Simon Mitchell
Patient-specific computational models predict prognosis in B cell lymphoma by quantifying pro-proliferative and anti-apoptotic signatures from genetic sequencing data. Blood cancer journal 14 (1) (2024)
Hussein N Al-Ali, Scott J Crichton, Charlene Fabian, Christopher J Pepper, David R Butcher, Fiona C Dempsey, Christopher N Parris
A therapeutic antibody targeting annexin-A1 inhibits cancer cell growth in vitro and in vivo. Oncogene 43 (8) (2024)
Hussein N Al-Ali, Scott J Crichton, Charlene Fabian, Christopher J Pepper, David R Butcher, Fiona C Dempsey, Christopher N Parris
A therapeutic antibody targeting annexin-A1 inhibits cancer cell growth in vitro and in vivo. Oncogene 43 (8) (2024)
Richard Norris, John Jones, Erika Mancini, Timothy Chevassut, Fabio A Simoes, Christopher J Pepper, Andrea G S Buggins, Simon Mitchell
Patient-specific computational models predict prognosis in B cell lymphoma by quantifying pro-proliferative and anti-apoptotic signatures from genetic sequencing data. Blood cancer journal 14 (1) (2024)
Richard Norris, John Jones, Erika Mancini, Timothy Chevassut, Fabio A Simoes, Christopher J Pepper, Andrea G S Buggins, Simon Mitchell
Patient-specific computational models predict prognosis in B cell lymphoma by quantifying pro-proliferative and anti-apoptotic signatures from genetic sequencing data. Blood cancer journal 14 (1) (2024)
Hussein N Al-Ali, Scott J Crichton, Charlene Fabian, Christopher J Pepper, David R Butcher, Fiona C Dempsey, Christopher N Parris
A therapeutic antibody targeting annexin-A1 inhibits cancer cell growth in vitro and in vivo. Oncogene 43 (8) (2024)
Hussein N Al-Ali, Scott J Crichton, Charlene Fabian, Christopher J Pepper, David R Butcher, Fiona C Dempsey, Christopher N Parris
A therapeutic antibody targeting annexin-A1 inhibits cancer cell growth in vitro and in vivo. Oncogene 43 (8) (2024)
Hussein N Al-Ali, Scott J Crichton, Charlene Fabian, Christopher J Pepper, David R Butcher, Fiona C Dempsey, Christopher N Parris
A therapeutic antibody targeting annexin-A1 inhibits cancer cell growth in vitro and in vivo. Oncogene 43 (8) (2024)
Evan A Mulligan, Susan J Tudhope, Jill E Hunter, Arabella E G Clift, Sarah L Elliott, Geoffrey P Summerfield, Jonathan Wallis, Christopher J Pepper, Barabara Durkacz, Stephany Veuger, Elaine Willmore
Expression and Activity of the NF-κB Subunits in Chronic Lymphocytic Leukaemia: A Role for RelB and Non-Canonical Signalling. Cancers 15 (19) (2023)
Thomas A Burley, Andrew Hesketh, Giselda Bucca, Emma Kennedy, Eleni E Ladikou, Benjamin P Towler, Simon Mitchell, Colin P Smith, Christopher Fegan, Rosalynd Johnston, Andrea G S Buggins, Christopher J Pepper
Elucidation of Focal Adhesion Kinase as a Modulator of Migration and Invasion and as a Potential Therapeutic Target in Chronic Lymphocytic Leukemia. Cancers 14 (7) (2022)
Thomas A Burley, Emma Kennedy, Georgia Broad, Melanie Boyd, David Li, Timothy Woo, Christopher West, Eleni E Ladikou, Iona Ashworth, Christopher Fegan, Rosalynd Johnston, Simon Mitchell, Simon P Mackay, Andrea G S Buggins, Christopher J Pepper
Targeting the Non-Canonical NF-κB Pathway in Chronic Lymphocytic Leukemia and Multiple Myeloma. Cancers 14 (6) (2022)
Emma Kennedy, Eve Coulter, Emma Halliwell, Núria Profitós-Pelejà, Elisabeth Walsby, Barnaby Clark, Elizabeth H Phillips, Thomas A Burley, Christopher Iain Jones, Stephen Devereux, Christopher D Fegan, Rosalynd Johnston, Timothy J T Chevassut, Ralph Schulz, Martina Seiffert, Angelo Agathanggelou, Ceri E Oldreive, Nicholas Davies, Tatjana Stankovic, Triantafillos Liloglou, Christopher J Pepper, Andrea G S Buggins
TLR9 expression in chronic lymphocytic leukemia identifies a promigratory subpopulation and novel therapeutic target. Blood 137 (22) (2021)
Riccardo Bomben, Francesca Maria Rossi, Filippo Vit, Tamara Bittolo, Tiziana D'Agaro, Antonella Zucchetto, Erika Tissino, Federico Pozzo, Elena Vendramini, Massimo Degan, Eva Zaina, Ilaria Cattarossi, Paola Varaschin, Paola Nanni, Michele Berton, Alessandra Braida, Jerry Polesel, Jared A Cohen, Enrico Santinelli, Annalisa Biagi, Massimo Gentile, Fortunato Morabito, Gilberto Fronza, Gabriele Pozzato, Giovanni D'Arena, Jacopo Olivieri, Pietro Bulian, Christopher J Pepper, Anna Hockaday, Anna Schuh, Peter Hillmen, Davide Rossi, Annalisa Chiarenza, Francesco Zaja, Francesco Di Raimondo, Giovanni Del Poeta, Valter Gattei
TP53 Mutations with Low Variant Allele Frequency Predict Short Survival in Chronic Lymphocytic Leukemia. Clinical cancer research : an official journal of the American Association for Cancer Research 27 (20) (2021)
Andrea G S Buggins, Antonella Zucchetto, Kevin Norris, Erika Tissino, Jerry Polesel, Zarni Soe, David John Allsup, Anna Hockaday, Pei Loo Ow, Peter Hillmen, Andrew Rawstron, Daniel Catovsky, Pietro Bulian, Riccardo Bomben, Duncan M Baird, Christopher D Fegan, Valter Gattei, Christopher J Pepper
Combined analysis of IGHV mutations, telomere length and CD49d identifies long-term progression-free survivors in TP53 wild-type CLL treated with FCR-based therapies. Leukemia (2021)
Wei-Yu Lin, Sarah E Fordham, Nicola Sunter, Claire Elstob, Thahira Rahman, Elaine Willmore, Colin Shepherd, Gordon Strathdee, Tryfonia Mainou-Fowler, Rachel Piddock, Hannah Mearns, Timothy Barrow, Richard S Houlston, Helen Marr, Jonathan Wallis, Geoffrey Summerfield, Scott Marshall, Andrew Pettitt, Christopher J Pepper, Christopher Fegan, Francesco Forconi, Martin J S Dyer, Sandrine Jayne, April Sellors, Anna Schuh, Pauline Robbe, David Oscier, James Bailey, Syed Rais, Alison Bentley, Lynn Cawkwell, Paul Evans, Peter Hillmen, Guy Pratt, David John Allsup, James M Allan
Genome-wide association study identifies risk loci for progressive chronic lymphocytic leukemia. Nature communications 12 (1) (2021)
Suliman Abdallah Alsagaby, Rajendran Vijayakumar, Mariappan Premanathan, Suresh Mickymaray, Wael Alturaiki, Raid S Al-Baradie, Saleh Alghamdi, Mohammad Azhar Aziz, Fahad A Alhumaydhi, Faisal Abdulrahman Alzahrani, Ameen S S Alwashmi, Waleed Al Abdulmonem, Naif Khalaf Alharbi, Christopher J Pepper
Transcriptomics-Based Characterization of the Toxicity of ZnO Nanoparticles Against Chronic Myeloid Leukemia Cells. International journal of nanomedicine 15 (2020)
Eleni E Ladikou, Timothy J T Chevassut, Christopher J Pepper, Andrea G S Buggins
Dissecting the role of the CXCL12/CXCR4 axis in acute myeloid leukaemia. British journal of haematology 189 (5) (2020)
Laura Escudero, Kez Cleal, Kevin Ashelford, Christopher Fegan, Christopher J Pepper, Kate Liddiard, Duncan M Baird
Telomere fusions associate with coding sequence and copy number alterations in CLL. Leukemia 33 (8) (2019)
Jason P Twohig, Ana Cardus Figueras, Robert Andrews, Florian Wiede, Benjamin C Cossins, Alicia Derrac Soria, Myles J Lewis, Michael J Townsend, David Millrine, Jasmine Li, David G Hill, Javier Uceda Fernandez, Xiao Liu, Barbara Szomolay, Christopher J Pepper, Philip R Taylor, Costantino Pitzalis, Tony Tiganis, Nigel M Williams, Gareth W Jones, Simon A Jones
Activation of naïve CD4+ T cells re-tunes STAT1 signaling to deliver unique cytokine responses in memory CD4+ T cells. Nature immunology 20 (4) (2019)
Lauren Elston, Christopher Fegan, Robert K Hills, Shaikh S Hashimdeen, Elisabeth Walsby, Peter Henley, Christopher J Pepper, Stephen T Man
Increased frequency of CD4+ PD-1+ HLA-DR+ T cells is associated with disease progression in CLL. British journal of haematology 188 (6) (2019)
Molly Went, Amit Sud, Helen Speedy, Nicola J Sunter, Asta Försti, Philip J Law, David C Johnson, Fabio Mirabella, Amy Holroyd, Ni Li, Giulia Orlando, Niels Weinhold, Mark van Duin, Bowang Chen, Jonathan S Mitchell, Larry Mansouri, Gunnar Juliusson, Karin E Smedby, Sandrine Jayne, Aneela Majid, Claire Dearden, David J Allsup, James R Bailey, Guy Pratt, Christopher J Pepper, Chris Fegan, Richard Rosenquist, Rowan Kuiper, Owen W Stephens, Uta Bertsch, Peter Broderick, Hermann Einsele, Walter Martin Gregory, Jens Hillengass, Per Hoffmann, Graham H Jackson, Karl-Heinz Jöckel, Jolanta Nickel, Markus M Nöthen, Miguel Inacio da Silva Filho, Hauke Thomsen, Brian A Walker, Annemiek Broyl, Faith E Davies, Markus Hansson, Hartmut Goldschmidt, Martin J S Dyer, Martin Kaiser, Pieter Sonneveld, Gareth J Morgan, Kari Hemminki, Björn Nilsson, Daniel Catovsky, James M Allan, Richard S Houlston
Genetic correlation between multiple myeloma and chronic lymphocytic leukaemia provides evidence for shared aetiology. Blood cancer journal 9 (1) (2018)
Marta Pasikowska, Elisabeth Walsby, Benedetta Apollonio, Kirsty Cuthill, Elizabeth Phillips, Eve Coulter, Maria Serena Longhi, Yun Ma, Deborah Yallop, Linda D Barber, Piers Patten, Chris Fegan, Alan G Ramsay, Christopher J Pepper, Stephen Devereux, Andrea G S Buggins
Phenotype and immune function of lymph node and peripheral blood CLL cells are linked to transendothelial migration. Blood 128 (4) (2016)

Christopher J Pepper.css-eqlu8i{font-size:small;padding-left:4px;} (Chris Pepper, Chris J Pepper, Christopher Pepper)

Publication Activity (10 Years)

Top Topics

Top Venues

Christopher J Pepper (Chris Pepper, Chris J Pepper, Christopher Pepper)